Home Back

Non-invasive and Cardiac Catheterization Assessment Form for the Safety of Recommended Surgery for Congenital Heart Disease with Systemic to Pulmonary Shunt

Symptoms
Feeding difficulties
Please select
Feeding difficulties
None
Persistent
Improved
Activity level
Please select
Activity level
Normal
Decreased
Signs
Murmur
Please select
Murmur
Loud
Decreased from loud
Decreased from loud
Soft
SpO2
Non-cyanotic congenital heart disease
Please select
Non-cyanotic congenital heart disease
≥95%
<95% and ≥95% after nasal cannula oxygen
<95% and <95% after nasal cannula oxygen
Cyanotic congenital heart disease
Please select
Cyanotic congenital heart disease
Increase ≥5% after nasal cannula oxygen
Increase <5% after nasal cannula oxygen
Age
Surgical age
Please select
Surgical age
Within recommended surgical age
≤1.5 times the upper limit of recommended surgical age
>1.5 times the upper limit of recommended surgical age
Auxiliary examination
Chest X-ray
Please select
Chest X-ray
Normal heart size, no pulmonary vascular dilation
Enlarged heart, pulmonary vascular dilation, visible pulmonary vascular markings in the lateral lung fields
Slightly enlarged heart, normal heart size, or reduced heart size, pulmonary vascular dilation with abrupt narrowing (cut-off image)
ECG
Please select
ECG
Tricuspid valve pre-shunt: no right ventricular enlargement
Tricuspid valve pre-shunt: right ventricular enlargement
Tricuspid valve post-shunt: left ventricular enlargement
Tricuspid valve post-shunt: biventricular enlargement
Tricuspid valve post-shunt: right ventricular enlargement
Echocardiographic estimation of pulmonary artery pressure
Please select
Echocardiographic estimation of pulmonary artery pressure
Measurable, no PH
Measurable, PH: tricuspid valve pre-shunt
Measurable, PH: tricuspid valve post-shunt
Unmeasurable PH: main pulmonary artery not widened (<1.0 times ascending aorta diameter)
Unmeasurable PH: main pulmonary artery not significantly widened (1.0~1.5 times ascending aorta diameter)
Unmeasurable PH: main pulmonary artery not significantly widened (1.0~1.5 times ascending aorta diameter)
Score:

Result Interpretation

BCPS, bidirectional cavopulmonary shunt; TCPC, total cavopulmonary connection; mPAP, mean pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure, PVRI, pulmonary vascular resistance index. If the score of children who can achieve biventricular repair in non-invasive assessment is >8 points, and the score of children who can achieve univentricular repair is >6 points, they are considered high-risk surgical candidates. These children are more likely to develop reactive pulmonary hypertension and pulmonary hypertensive crises during the perioperative period. It is recommended that these children undergo cardiac catheterization before surgery.

Children with a cardiac catheterization score ≥8 points are not recommended for radical surgery. For children undergoing univentricular repair, achieving Fontan circulation is crucial, and normal or even lower than normal pulmonary vascular resistance is key to surgical success. Children with a cardiac catheterization score ≤4 points can be followed up if ≤6 months, and BCPS or TCPC surgery can be performed if >6 months. Children with a score of 5-7 points are recommended to undergo pulmonary artery banding to protect the pulmonary vessels, with follow-up every 3 months. Based on the follow-up results, it will be decided whether BCPS or TCPC surgery is needed. Children with a score >8 points are currently not considered for BCPS or TCPC surgery.

Favorite